Sonire Therapeutics Overview

  • Year Founded
  • 2020

Year Founded

  • Status
  • Private

  • Employees
  • 27

Employees

  • Latest Deal Type
  • Grant

  • Latest Deal Amount
  • $13M

  • Investors
  • 30

Sonire Therapeutics General Information

Description

Developer of high-intensity focused ultrasound therapy systems designed to revolutionize medical therapy for the treatment of cancer patients. The company offers precise tissue targeting and real-time imaging capabilities, enabling healthcare professionals specializing in oncology and non-invasive surgery to deliver effective treatments with enhanced accuracy and patient comfort.

Contact Information

Website
www.sonire-therapeutics.com
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 803 Nihonbashi Life Science Building 2
  • 3-11-5 Nihonbashi Honcho, Chuo-ku
  • Tokyo, 103-0023
  • Japan
Primary Industry
Therapeutic Devices
Vertical(s)
Life Sciences, Oncology
Corporate Office
  • 803 Nihonbashi Life Science Building 2
  • 3-11-5 Nihonbashi Honcho, Chuo-ku
  • Tokyo, 103-0023
  • Japan

Sonire Therapeutics Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sonire Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Grant 17-Jun-2026 $13M Completed Generating Revenue
9. Later Stage VC (Series C) 23-Jan-2026 Completed Generating Revenue
8. Accelerator/Incubator Completed Generating Revenue
7. Grant 01-Jan-2024 Completed Generating Revenue
6. Accelerator/Incubator 09-Jun-2023 Completed Generating Revenue
5. Early Stage VC (Series B) 30-Nov-2022 Completed Generating Revenue
4. Accelerator/Incubator 20-Dec-2021 Completed Generating Revenue
3. Accelerator/Incubator 30-Jul-2021 Completed Generating Revenue
2. Early Stage VC (Series A) 11-Jun-2021 $5.3M $5.3M Completed Generating Revenue
1. Accelerator/Incubator 01-Jan-2021 Completed Startup
To view Sonire Therapeutics’s complete valuation and funding history, request access »

Sonire Therapeutics Cap Table

Stock # of Shares
Authorized		 Par Value Dividend Rate (%) Original
Issue Price		 Liquidation Liquidation
Pref. Multiple		 Conversion Price % Owned
A3 Preferred
Class B preferred
A2 Preferred 25,000 $14.06 $14.06 1x $14.06 3.07%
Class A preferred 168,250 $22.15 $22.15 1x $22.15 20.66%
To view Sonire Therapeutics’s complete cap table history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Request a free trial

Sonire Therapeutics Patents

  • 105

    Total Documents Applications and Grants

  • Total Patents Families

  • 69

    Granted

  • 25

    Pending

  • Expiring in next 12 mo

Sonire Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
JP-7887211-B1 Hifu irradiation device Active 06-Oct-2025
JP-7889912-B1 Ultrasonic phantom Active 22-Jul-2025
JP-2026174808-A Ultrasonic therapy device Active 21-Apr-2025
JP-7904639-B1 Ultrasonic therapy device Active 21-Apr-2025
WO-2026225033-A1 Ultrasonic therapy device Pending 21-Apr-2025
To view Sonire Therapeutics’s complete patent history, request access »

Sonire Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sonire Therapeutics Investors (30)

Investor Name Investor Type Holding Investor Since Participating Rounds
New Energy and Industrial Technology Development Organization Government
Carbon Ventures (Japan) Corporate Venture Capital Minority
Angel (individual) Minority
SLINGSHOT (Singapore) Other
MedTech Innovator Accelerator/Incubator Minority
You’re viewing 5 of 30 investors. Get the full list »

Ready to get started?

Request a free trial

Sonire Therapeutics FAQs

  • When was Sonire Therapeutics founded?

    Sonire Therapeutics was founded in 2020.

  • Where is Sonire Therapeutics headquartered?

    Sonire Therapeutics is headquartered in Tokyo, Japan.

  • What is the size of Sonire Therapeutics?

    Sonire Therapeutics has 27 total employees.

  • What industry is Sonire Therapeutics in?

    Sonire Therapeutics’s primary industry is Therapeutic Devices.

  • Is Sonire Therapeutics a private or public company?

    Sonire Therapeutics is a Private company.

  • What is Sonire Therapeutics’s current revenue?

    The current revenue for Sonire Therapeutics is .

  • How much funding has Sonire Therapeutics raised over time?

    Sonire Therapeutics has raised $39.9M.

  • Who are Sonire Therapeutics’s investors?

    New Energy and Industrial Technology Development Organization, Carbon Ventures (Japan), , SLINGSHOT (Singapore), and MedTech Innovator are 5 of 30 investors who have invested in Sonire Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process